Cargando…
Novel microtubule-targeting agents – the epothilones
Epothilones are a new class of antimicrotubule agents currently in clinical trials. Their chemical structures are distinct from taxanes and are more amenable to synthetic modification. Six epothilones have been studied in preclinical and clinical trials: patupilone (epothilone B), ixabepilone (BMS24...
Autores principales: | Cheng, Kit L, Bradley, Thomas, Budman, Daniel R |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2727900/ https://www.ncbi.nlm.nih.gov/pubmed/19707459 |
Ejemplares similares
-
Synthesis, Microtubule-Binding Affinity, and Antiproliferative Activity of New Epothilone Analogs and of an EGFR-Targeted Epothilone-Peptide Conjugate
por: Gaugaz, Fabienne Zdenka, et al.
Publicado: (2019) -
Microtubule Alterations Occur Early in Experimental Parkinsonism and The Microtubule Stabilizer Epothilone D Is Neuroprotective
por: Cartelli, Daniele, et al.
Publicado: (2013) -
Resistance to anti-tubulin agents: From vinca alkaloids to epothilones
por: Krause, Werner
Publicado: (2019) -
Effects of Microtubule Stabilization by Epothilone B Depend on the Type and Age of Neurons
por: Jang, Eun-Hae, et al.
Publicado: (2016) -
Epothilones as Natural Compounds for Novel Anticancer Drugs Development
por: Villegas, Cecilia, et al.
Publicado: (2023)